Module 14 | Slide 1 of 38 2013 Basic Principles of GMP GMP for Sterile Pharmaceutical Products Part...

38
Module 14 | Slide 1 of 38 2013 Basic Principles of GMP GMP for Sterile Pharmaceutica l Products Part 3 Annex 6. TRS 961, 2011

Transcript of Module 14 | Slide 1 of 38 2013 Basic Principles of GMP GMP for Sterile Pharmaceutical Products Part...

Page 1: Module 14 | Slide 1 of 38 2013 Basic Principles of GMP GMP for Sterile Pharmaceutical Products Part 3 Annex 6. TRS 961, 2011.

Module 14 | Slide 1 of 38 2013

Basic Principles of GMPBasic Principles of GMP

GMP for

Sterile Pharmaceutical

Products

Part 3 Annex 6. TRS 961, 2011

Page 2: Module 14 | Slide 1 of 38 2013 Basic Principles of GMP GMP for Sterile Pharmaceutical Products Part 3 Annex 6. TRS 961, 2011.

Module 14 | Slide 2 of 38 2013

Sterile ProductionSterile Production

Methods of sterilization

Page 3: Module 14 | Slide 1 of 38 2013 Basic Principles of GMP GMP for Sterile Pharmaceutical Products Part 3 Annex 6. TRS 961, 2011.

Module 14 | Slide 3 of 38 2013

Sterile ProductionSterile Production

Sterilization

Terminally sterilized by heat in final container whenever possible

When not possible - alternative method of terminal sterilization following filtration and/or aseptic processing.

 Use of moist or dry heat, by irradiation with ionizing radiation (noting that ultraviolet irradiation is not normally an acceptable method of sterilization), by ethylene oxide (or other suitable gaseous sterilizing agents), or by filtration with subsequent aseptic filling of sterile final containers

Heat sterilization is the method of choice 5.1 – 5.2

Page 4: Module 14 | Slide 1 of 38 2013 Basic Principles of GMP GMP for Sterile Pharmaceutical Products Part 3 Annex 6. TRS 961, 2011.

Module 14 | Slide 4 of 38 2013

Sterile ProductionSterile Production

Sterilization

Minimal microbial contamination of starting materials

Bioburden monitored before sterilization

All sterilization processes should be validated

Particular attention in case sterilization method is not in accordance with pharmacopoeial standards or other national standards, or when it is used for a preparation that is not a simple aqueous or oily solution, for example, colloidal suspensions 5.3 – 5.4

Page 5: Module 14 | Slide 1 of 38 2013 Basic Principles of GMP GMP for Sterile Pharmaceutical Products Part 3 Annex 6. TRS 961, 2011.

Module 14 | Slide 5 of 38 2013

Sterile ProductionSterile Production

Before adopting a sterilization process:

Demonstrate the suitability for the product

Prove its efficacy in achieving the desired sterilizing conditions in all parts of each type (physical measurements and by biological indicators)

Validated loading patterns

Whole of the material subjected to the required treatment

Verified at scheduled intervals, at least annually, and whenever significant modifications have been made to the equipment - records kept of the results 5.5 -5.6, 5.9

Page 6: Module 14 | Slide 1 of 38 2013 Basic Principles of GMP GMP for Sterile Pharmaceutical Products Part 3 Annex 6. TRS 961, 2011.

Module 14 | Slide 6 of 38 2013

Sterile ProductionSterile Production

Biological indicators:– For additional monitoring

– Stored and used according to the manufacturer’s instructions

– Their quality checked by positive controls

– Avoid any transfer of microbial contamination from them

Differentiate between “to be sterilized” and “sterilized” product

Each basket / tray clearly labelled (material, batch number etc)

Autoclave tape can also be used 5.7 -5.8

Page 7: Module 14 | Slide 1 of 38 2013 Basic Principles of GMP GMP for Sterile Pharmaceutical Products Part 3 Annex 6. TRS 961, 2011.

Module 14 | Slide 7 of 38 2013

Sterile ProductionSterile Production

Sterilization records available for each sterilization run

Sterilization records approved as part of the batch-release procedure

Can you name the different methods of sterilization?

5.10

Page 8: Module 14 | Slide 1 of 38 2013 Basic Principles of GMP GMP for Sterile Pharmaceutical Products Part 3 Annex 6. TRS 961, 2011.

Module 14 | Slide 8 of 38 2013

Sterile ProductionSterile Production

Different methods of sterilization include:

Terminal sterilization:– Heat (Dry heat and moist heat)– Radiation– Gas and fumigants

Aseptic processing by filtration

Page 9: Module 14 | Slide 1 of 38 2013 Basic Principles of GMP GMP for Sterile Pharmaceutical Products Part 3 Annex 6. TRS 961, 2011.

Module 14 | Slide 9 of 38 2013

Sterile ProductionSterile Production

Terminal sterilization

Sterilization by heat (general aspects)

Record each heat-sterilization cycle - equipment of suitable accuracy and precision, e.g. on a time/ temperature chart. Reviewed and approved as part of the batch release

This temperature probe situated at the validated coolest part and temperature checked against a second independent probe

May also use chemical or biological indicators (in addition)

Whole of the load to reach the required temperature (Validated time) - no contamination of a sterilized load during cooling 6.1 – 6.3

Page 10: Module 14 | Slide 1 of 38 2013 Basic Principles of GMP GMP for Sterile Pharmaceutical Products Part 3 Annex 6. TRS 961, 2011.

Module 14 | Slide 10 of 38 2013

Sterile ProductionSterile Production

Sterilization by moist heat

Monitor temperature and pressure (and time)

Control instrumentation independent of monitoring instrumentation and recording charts

Validated automated control and monitoring systems used

Register system and cycle faults and observed by the operator

If a drain at the bottom of the chamber – consider recording the temperature at this position

Regular leak tests on the chamber 6.4

Page 11: Module 14 | Slide 1 of 38 2013 Basic Principles of GMP GMP for Sterile Pharmaceutical Products Part 3 Annex 6. TRS 961, 2011.

Module 14 | Slide 11 of 38 2013

Sterile ProductionSterile Production

Use sealed containers or wrapped in a material that allows the removal of air and the penetration of steam but prevents recontamination after sterilization

Specially designed autoclavable stainless steel containers allow steam to enter and air to leave

Suitable quality steam (chemical, microbiological and endotoxin analysis of condensate and physical examination of steam (such as dryness, superheat, and non-condensable gases); no additives at a level that could cause contamination (product or equipment)

Steam tested regularly – SOP, specification, review results

6.5 – 6.6

Page 12: Module 14 | Slide 1 of 38 2013 Basic Principles of GMP GMP for Sterile Pharmaceutical Products Part 3 Annex 6. TRS 961, 2011.

Module 14 | Slide 12 of 38 2013

Sterile ProductionSterile Production

Autoclave

Page 13: Module 14 | Slide 1 of 38 2013 Basic Principles of GMP GMP for Sterile Pharmaceutical Products Part 3 Annex 6. TRS 961, 2011.

Module 14 | Slide 13 of 38 2013

Sterile ProductionSterile Production

Bowie Dick testWhat is it?When is it done?

How do you know whether it “Passes” or “Fails”?

What action do you take when it fails?

Page 14: Module 14 | Slide 1 of 38 2013 Basic Principles of GMP GMP for Sterile Pharmaceutical Products Part 3 Annex 6. TRS 961, 2011.

Module 14 | Slide 14 of 38 2013

Sterile ProductionSterile Production

Some points to consider

Vacuum and pressure hold tests

Bowie Dick test

Use of Biological Indicators and SAL

Heat distribution studies

Heat penetration studies

Loading patterns

Quality of steam

Calibration op sensors

Coolest part of the load

Dwell time

D- value

Z- value

F0-value

Variation in temperature in a sensor, and between sensors

Page 15: Module 14 | Slide 1 of 38 2013 Basic Principles of GMP GMP for Sterile Pharmaceutical Products Part 3 Annex 6. TRS 961, 2011.

Module 14 | Slide 15 of 38 2013

Sterile ProductionSterile Production

Dry heatSterilizer

Entry

Sterilizing tunnel and cooling zone

Page 16: Module 14 | Slide 1 of 38 2013 Basic Principles of GMP GMP for Sterile Pharmaceutical Products Part 3 Annex 6. TRS 961, 2011.

Module 14 | Slide 16 of 38 2013

Sterile ProductionSterile Production

Sterilization by dry heat

Suitable for non-aqueous liquids or dry-powder products

Air circulation within the chamber

Maintain positive pressure to prevent the entry of non-sterile air

Air supplied through a HEPA filter

For pyrogen removal – validate through challenge tests using endotoxins

6.7

Page 17: Module 14 | Slide 1 of 38 2013 Basic Principles of GMP GMP for Sterile Pharmaceutical Products Part 3 Annex 6. TRS 961, 2011.

Module 14 | Slide 17 of 38 2013

Sterile ProductionSterile Production

Sterilization by radiation

For heat-sensitive materials and products and only allowed if no negative effects on the product has been confirmed

Manufacturer is responsible when done by an outside contractor

Radiation dose to be measured. Sufficient number of calibrated, independent dosimeters used, quantitative measurement - read shortly after exposure

Colour discs to differentiate/indicate before and after sterilization

Ultraviolet irradiation is not an acceptable method for terminal sterilization 6.8 – 6.10

Page 18: Module 14 | Slide 1 of 38 2013 Basic Principles of GMP GMP for Sterile Pharmaceutical Products Part 3 Annex 6. TRS 961, 2011.

Module 14 | Slide 18 of 38 2013

Sterile ProductionSterile Production

Validated procedures followed

Considered variations in the density of the packages

Material-handling procedures followed to prevent any mix-up of irradiated and non-irradiated materials. (Each package should carry a radiation-sensitive indicator to show whether or not it has been subjected to radiation treatment)

The total radiation dose administered within a predetermined period 6.11 – 6.13

Page 19: Module 14 | Slide 1 of 38 2013 Basic Principles of GMP GMP for Sterile Pharmaceutical Products Part 3 Annex 6. TRS 961, 2011.

Module 14 | Slide 19 of 38 2013

Sterile ProductionSterile Production

Sterilization by gases and fumigants (E.g. hydrogen peroxide vapour). Ethylene oxide should be used only when no other method is practicable.

This method used only for finished products where there is no suitable alternative

Proof of no damaging effect on the product and that degassing reduces any residual gas and reaction products to defined acceptable limits as specified in specifications

Direct contact between gas and microorganisms – ensure avoiding the presence of organisms enclosed in materials such as crystals or dried protein. Consider the nature and quantity of packaging materials 16.14 – 16.16

Page 20: Module 14 | Slide 1 of 38 2013 Basic Principles of GMP GMP for Sterile Pharmaceutical Products Part 3 Annex 6. TRS 961, 2011.

Module 14 | Slide 20 of 38 2013

Sterile ProductionSterile Production

Sterilization by gases and fumigants (E.g. ethyleneoxide and hydrogen peroxide vapour)

Before exposure to the gas - equilibrium with humidity and temperature

Biological indicators (BIs)– Use to monitor each cycle

– Stored and used appropriately

– Checked by positive controls

Records include time, pressure, temperature, humidity, gas concentration (chart). Records to be part of the batch record

Store under ventilated condition after sterilization (validated)16.17 – 16.21

Page 21: Module 14 | Slide 1 of 38 2013 Basic Principles of GMP GMP for Sterile Pharmaceutical Products Part 3 Annex 6. TRS 961, 2011.

Module 14 | Slide 21 of 38 2013

Sterile ProductionSterile Production

Aseptic processing and sterilization by filtration

Page 22: Module 14 | Slide 1 of 38 2013 Basic Principles of GMP GMP for Sterile Pharmaceutical Products Part 3 Annex 6. TRS 961, 2011.

Module 14 | Slide 22 of 38 2013

Sterile ProductionSterile Production

Aseptic processing and sterilization by filtration

Objective to maintain the sterility of a product that is assembled from sterile components – therefore conditions such to prevent microbial contamination

Maintain sterility of the components and the product by controlling:– environment;– personnel;– critical surfaces;– container/closure sterilization and transfer procedures;– the maximum holding period of the product before filling into the final

container; and– the sterilizing filter 7.1 – 7.3

Page 23: Module 14 | Slide 1 of 38 2013 Basic Principles of GMP GMP for Sterile Pharmaceutical Products Part 3 Annex 6. TRS 961, 2011.

Module 14 | Slide 23 of 38 2013

Sterile ProductionSterile Production

Aseptic processing and sterilization by filtration

Certain solutions and liquids cannot be sterilized in the final container

These can be filtered through a sterile filter of nominal pore size 0.22 micron (or less), or with at least equivalent microorganism-retaining properties

Into a previously sterilized container

Where possible use also some degree of heat treatment

When sterilization in the final container is possible then filtration alone is not considered sufficient 7.4

Page 24: Module 14 | Slide 1 of 38 2013 Basic Principles of GMP GMP for Sterile Pharmaceutical Products Part 3 Annex 6. TRS 961, 2011.

Module 14 | Slide 24 of 38 2013

Sterile ProductionSterile Production

A double-filter layer or second filtration through a further sterilized microorganism-retaining filter immediately prior to filling is recommended - as close as possible to the filling point.

Filters should not shed fibres. No asbestos-containing filters used

Filter integrity verified before and after use (e.g. bubble point, diffusive flow or pressure hold test

Filter used for one working day - unless otherwise validated

Filter not to remove ingredients from product; not releasing any substance into the product

7.5 – 7.9

Page 25: Module 14 | Slide 1 of 38 2013 Basic Principles of GMP GMP for Sterile Pharmaceutical Products Part 3 Annex 6. TRS 961, 2011.

Module 14 | Slide 25 of 38 2013

Sterile ProductionSterile Production

Integrity of critical gas and air vent filters, as well as other filters

Validate time and pressure for a known volume of bulk solution

Significant differences during manufacturing investigated

7.5 – 7.7

Page 26: Module 14 | Slide 1 of 38 2013 Basic Principles of GMP GMP for Sterile Pharmaceutical Products Part 3 Annex 6. TRS 961, 2011.

Module 14 | Slide 26 of 38 2013

Sterile ProductionSterile Production

Isolator

technology

Page 27: Module 14 | Slide 1 of 38 2013 Basic Principles of GMP GMP for Sterile Pharmaceutical Products Part 3 Annex 6. TRS 961, 2011.

Module 14 | Slide 27 of 38 2013

Sterile ProductionSterile Production

Isolator technology

Minimize human interventions in processing areas and thus contamination. (Risk: Puncture and leakage)

Different designs. (Also single-door, double-door, and fully-sealed transfer devices)

Required air quality in and around (background) of the isolator

Greatest chance of contamination during transfer of materials into and out of the unit

Background at least Grade D 8.1 – 8.3

Page 28: Module 14 | Slide 1 of 38 2013 Basic Principles of GMP GMP for Sterile Pharmaceutical Products Part 3 Annex 6. TRS 961, 2011.

Module 14 | Slide 28 of 38 2013

Sterile ProductionSterile Production

Isolator technology

Used only after appropriate validation which covers e.g.:– Quality of the air inside isolator– Quality of air outside (background) the isolator– Sanitization of the isolator– Transfer process– Isolator integrity.

Routine monitoring of isolator which includes frequent leak testing of the isolator and the glove/sleeve system

8.4 – 8.5

Page 29: Module 14 | Slide 1 of 38 2013 Basic Principles of GMP GMP for Sterile Pharmaceutical Products Part 3 Annex 6. TRS 961, 2011.

Module 14 | Slide 29 of 38 2013

Sterile ProductionSterile Production

Blow/fill/seal technology

Page 30: Module 14 | Slide 1 of 38 2013 Basic Principles of GMP GMP for Sterile Pharmaceutical Products Part 3 Annex 6. TRS 961, 2011.

Module 14 | Slide 30 of 38 2013

Sterile ProductionSterile Production

Blow/fill/seal technology

Page 31: Module 14 | Slide 1 of 38 2013 Basic Principles of GMP GMP for Sterile Pharmaceutical Products Part 3 Annex 6. TRS 961, 2011.

Module 14 | Slide 31 of 38 2013

Sterile ProductionSterile Production

Purpose-built machines - one continuous operation

Aseptic production - Grade A air shower and installed in Grade C

– Grade A or B clothing used– Comply with the viable and non-viable limits at rest– Comply with viable limit in operation

When used for the production of products which are terminally sterilized - installed in at least a Grade D environment 9.1

Page 32: Module 14 | Slide 1 of 38 2013 Basic Principles of GMP GMP for Sterile Pharmaceutical Products Part 3 Annex 6. TRS 961, 2011.

Module 14 | Slide 32 of 38 2013

Sterile ProductionSterile Production

Particular attention to:

equipment design and qualification;

validation and reproducibility of cleaning-in-place and sterilization-in place;

background clean room environment;

operator training and clothing; and

interventions in the critical zone of the equipment including any aseptic assembly prior to the commencement of filling.

9.2

Page 33: Module 14 | Slide 1 of 38 2013 Basic Principles of GMP GMP for Sterile Pharmaceutical Products Part 3 Annex 6. TRS 961, 2011.

Module 14 | Slide 33 of 38 2013

Sterile ProductionSterile Production

Quality Control and sterility testing

Page 34: Module 14 | Slide 1 of 38 2013 Basic Principles of GMP GMP for Sterile Pharmaceutical Products Part 3 Annex 6. TRS 961, 2011.

Module 14 | Slide 34 of 38 2013

Sterile ProductionSterile Production

Quality control

Review BPRs, environmental quality records with sterility tests

Injectable products – WFI, intermediate, finished product - monitored for endotoxins. Validated pharmacopoeial method

Failures investigated - necessary action should taken

Rapid microbiological methods can be used if validated and a comparative assessment was done

2.4 – 2.5

Page 35: Module 14 | Slide 1 of 38 2013 Basic Principles of GMP GMP for Sterile Pharmaceutical Products Part 3 Annex 6. TRS 961, 2011.

Module 14 | Slide 35 of 38 2013

Sterile ProductionSterile Production

Quality control

Sterility test is only the last in a series of control measures

Validated test to be used for the product(s) concerned.

 Samples taken to be representative of the whole of the batch e.g.

– aseptically prepared – samples from beginning and end of the batch and after any significant interruption of work

– heat sterilized in their final containers - from that coolest part of the load

Sterility assured through:– validation of the sterilization cycle (terminally sterilized products)– “media simulation” or “media fill” runs (aseptically processed)

2.1 – 2.3

Page 36: Module 14 | Slide 1 of 38 2013 Basic Principles of GMP GMP for Sterile Pharmaceutical Products Part 3 Annex 6. TRS 961, 2011.

Module 14 | Slide 36 of 38 2013

Sterile ProductionSterile Production

Quality control

Review BPRs, environmental quality records with sterility tests

Injectable products – WFI, intermediate, finished product - monitored for endotoxins. Validated pharmacopoeial method

Failures investigated - necessary action should taken

Rapid microbiological methods can be used if validated and a comparative assessment was done

2.4 – 2.5

Page 37: Module 14 | Slide 1 of 38 2013 Basic Principles of GMP GMP for Sterile Pharmaceutical Products Part 3 Annex 6. TRS 961, 2011.

Module 14 | Slide 37 of 38 2013

Sterile ProductionSterile Production

Quality control

The previous slides only highlight some quality control aspects

See also the Training Modules on Quality Control laboratories and Microbiology Laboratories

Page 38: Module 14 | Slide 1 of 38 2013 Basic Principles of GMP GMP for Sterile Pharmaceutical Products Part 3 Annex 6. TRS 961, 2011.

Module 14 | Slide 38 of 38 2013

Sterile ProductionSterile Production

Case Study and Assessment